While one of the drugs reportedly slated for fast-track review is the cholesterol pill Enlicitide decanoate, the other is its cancer therapy Sacituzumab tirumotecan.
GEE Group reports Q4 loss, misses revenue estimates amid tough staffing market and AI disruption. Company focuses on cost cuts and strategic AI integration.
Date: December 17, 2025 Introduction Ford Motor Company (NYSE: F) stands at a defining crossroads in the winter of 2025. Once the pioneer of the moving assembly line, the Dearborn-based automaker is currently navigating one of the most significant strategic pivots in its 122-year history. After a period of aggressive, multi-billion-dollar investment into pure electric [...]
The Nasdaq suffered an 418-point drop, marking its lowest close in nearly a month, while both the Dow and S&P 500 logged a fourth consecutive daily loss.
The financial markets, often perceived as bastions of rational decision-making, are, in reality, deeply swayed by the powerful currents of human emotion. As the global economy navigates its inherent cycles, the interplay of fear and greed emerges as a dominant force, particularly during periods of market downturns. This psychological phenomenon
As December 2025 draws to a close, global financial markets find themselves in a period of heightened volatility, a complex tapestry woven from disparate central bank strategies, a fragile global economic outlook, and persistent geopolitical tensions. Investors are grappling with significant shifts, most notably a projected interest rate cut by
The technology sector, a dominant force in global markets throughout 2025, is currently navigating a significant recalibration. A pronounced selloff, intensifying in mid-December, has sent tremors through Wall Street and beyond, raising critical questions about overvaluation, sustainable growth, and the future trajectory of the AI-driven boom. While the year saw
As of late 2025, a palpable shift is underway in the global financial markets, casting a long shadow of doubt over the sustainability of the tech-led growth era that has dominated the past decade. While technological innovation, particularly in Artificial Intelligence (AI), continues its rapid ascent, a growing chorus of
The burgeoning artificial intelligence industry, while promising unprecedented innovation, is simultaneously confronting a rising tide of risks that extend far beyond any single player like Oracle. As of late 2025, major AI developers and infrastructure providers are grappling with a complex interplay of financial sustainability concerns, intense market competition, a
The financial markets are currently experiencing a significant recalibration, with investor behavior data as of December 17, 2025, signaling a distinct "risk-off" posture despite underlying bullish sentiments for the year-end and into 2026. A widespread market-wide selloff is gripping Wall Street, leading to sharp declines across major U.S. indices
December 17, 2025 – In a surprising turn of events amidst a backdrop of persistent global market uncertainty, oil prices experienced a notable upward surge today. West Texas Intermediate (WTI) and Brent crude futures each rose by over 2%, reaching approximately $56.42 and $60.62 per barrel, respectively. This immediate
In November 2021, the electric vehicle (EV) manufacturer Rivian Automotive (NASDAQ: RIVN) made a thunderous debut on the Nasdaq, executing the largest U.S. initial public offering (IPO) in over five years, raising an astounding $11.9 billion. This monumental event, initially hailed as a beacon for the burgeoning EV
As the calendar pages turn towards 2026, a growing chorus of financial experts and institutions is sounding a distinct note of caution, warning investors to brace for a potentially challenging year ahead. This emerging consensus, articulated by strategists from major investment banks and independent market analysts alike, paints a picture
Wall Street experienced a significant downturn last week, culminating in major indices hitting three-week lows on Friday, December 12, 2025. The broad market retreat was fueled by a confluence of persistent worries, including a sudden cooling in the technology sector, particularly among artificial intelligence (AI) giants, and an overriding sense
While the drug was well tolerated with no new safety concerns, the drug yielded no positive treatment benefits in a study even at its highest dose of 40 mg.
Oracle (NYSE: ORCL) finds itself at the epicenter of a significant credit controversy, sending ripples of unease through investor circles and casting a shadow over its aggressive artificial intelligence (AI) expansion strategy. The immediate catalyst for this intensified scrutiny, particularly around December 17, 2025, was a widely reported, though denied,
The financial markets are currently grappling with a significant downturn, primarily fueled by a sharp decline in chip stocks, which have consequently dragged the broader technology sector and overall market lower. This widespread sell-off, observed prominently in mid-December 2025, stems from a confluence of factors including mounting concerns over potentially
